Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-009614
Filing Date
2025-03-04
Accepted
2025-03-04 06:34:53
Documents
107
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nkgn-20240930.htm   iXBRL 10-Q 2292104
2 EX-31.1 nkgenbiotechinc-ex311q32024.htm EX-31.1 8369
3 EX-31.2 nkgenbiotechinc-ex312q32024.htm EX-31.2 8403
4 EX-32.1 nkgenbiotechinc-ex321q32024.htm EX-32.1 7100
  Complete submission text file 0001628280-25-009614.txt   12832189

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nkgn-20240930.xsd EX-101.SCH 105831
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nkgn-20240930_cal.xml EX-101.CAL 78621
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nkgn-20240930_def.xml EX-101.DEF 681375
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nkgn-20240930_lab.xml EX-101.LAB 874840
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nkgn-20240930_pre.xml EX-101.PRE 828963
110 EXTRACTED XBRL INSTANCE DOCUMENT nkgn-20240930_htm.xml XML 2005305
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40427 | Film No.: 25701395
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)